tert-butyl 4-hydroxy-4-(3-methoxyphenyl)piperidine-1-carboxylate | 871112-35-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: tert-butyl 4-hydroxy-4-(3-methoxyphenyl)piperidine-1-carboxylate
• CAS: 871112-35-5
• 化学式: C₁₇H₂₅NO₄
• mdl: MFCD11849838
• 分子量: 307.39
• InChiKey: WYAWTKRZLYEDEC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.588
• 拓扑面积：
  59
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  tert-butyl 4-hydroxy-4-(3-methoxyphenyl)piperidine-1-carboxylate 在 盐酸 、 溶剂黄146 作用下， 生成 4-(3-methoxyphenyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid
  参考文献：
  名称：

  Design and synthesis of orally active inhibitors of TNF synthesis as anti-rheumatoid arthritis drugs

  摘要：

  A novel series of TNF inhibitors was identified based on the screening of existing MMP inhibitor libraries. Further SAR optimization led to the discovery of a novel lead compound. Its synthesis, efficacy in experimental animal models, and pharmacokinetic data are discussed. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.08.076
• 作为产物：
  描述：

  (3-methoxyphenyl)magnesium bromide 、 N-叔丁氧羰基-4-哌啶酮 生成 tert-butyl 4-hydroxy-4-(3-methoxyphenyl)piperidine-1-carboxylate
  参考文献：
  名称：

  4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators

  摘要：

  本发明公开了一种通用结构的4-氟-4-苯基哌啶-1-基μ拮抗剂及包含公式I化合物的制药组合物。这些化合物和组合物可用于治疗与结合阿片受体有关的疾病或症状，包括疼痛、肥胖、高度疼痛敏感性、炎症、骨关节炎、药物成瘾和癌症。这些化合物和组合物也可用于治疗迟发性运动障碍。

  公开号：

  US08859777B2

文献信息

• [EN] INDOLE DERIVATIVE AND USE FOR TREATMENT OF CANCER<br/>[FR] DÉRIVÉ D'INDOLE ET USAGE POUR LE TRAITEMENT DU CANCER
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2005118587A1

  公开（公告）日：2005-12-15

  The present invention relates to a compound represented by the formula (I’) wherein A is a benzene ring optionally having substituents, R1, R2a and R3 are each a hydrogen atom, a hydrocarbon group optionally having substituents or a heterocyclic group optionally having substituents, R1 and R2a may form a ring via X, when R1 and R2a form a ring via X, R1 and R2a are each a bond or a divalent C1-5 acyclic hydrocarbon group optionally having substituents, and X is a bond, an oxygen atom, an optionally oxidized sulfur atom or an imino group optionally having a substituent, provided that R1, R2a and X are not bonds at the same time, or a salt thereof, and an agent for inhibiting kinase (phosphorylation enzyme), which contains this compound or a prodrug thereof. The compound of the present invention has an inhibitory activity against kinase such as a vascular endothelial growth factor receptor (VEGFR) and the like, and is useful as an agent for the prophylaxis or threatment of cancer and the like.

  本发明涉及一种由式(I')表示的化合物，其中A是一个苯环，可选地具有取代基，R1、R2a和R3分别是氢原子，可选地具有取代基的碳氢基团或可选地具有取代基的杂环基团，R1和R2a可以通过X形成环，当R1和R2a通过X形成环时，R1和R2a分别是键或可选地具有取代基的二价C1-5非环烃基团，X是键，氧原子，可选地氧化的硫原子或可选地具有取代基的亚胺基团，前提是R1、R2a和X不同时为键，或其盐，以及含有该化合物或其前药的抑制激酶（磷酸化酶）的药剂。本发明的化合物对激酶如血管内皮生长因子受体（VEGFR）等具有抑制活性，并可用作预防或治疗癌症等疾病的药剂。
• 環状アミノ化合物
  申请人：第一三共株式会社

  公开号：JP2019137610A

  公开（公告）日：2019-08-22

  【課題】 本発明の課題は、皮膚透過性に優れるとともに皮膚刺激性を軽減した痛みを治療及び/又は予防するための新規な化合物を提供することである。【解決手段】 本発明の解決手段：式(I)の化合物、又は、その薬学的に許容される塩。【化１】(X：-CH2-等、Y：フェニル基等、R1：メチル基等、n：1等)【選択図】なし

  The problem of the present invention is to provide a novel compound for treating and/or preventing pain that has excellent skin permeability and reduces skin irritation. The solution of the present invention is a compound of formula (I) or its pharmaceutically acceptable salt. (Where X: -CH2- etc., Y: phenyl group etc., R1: methyl group etc., n: 1 etc.) No drawings are included.
• Indole Derivative and Use for Treatment of Cancer
  申请人：Nishikimi Yuji

  公开号：US20070254877A1

  公开（公告）日：2007-11-01

  The present invention relates to a compound represented by the formula wherein A is a benzene ring optionally having substituents, R 1 , R 2a and R 3 are each a hydrogen atom, a hydrocarbon group optionally having substituents or a heterocyclic group optionally having substituents, R 1 and R 2a may form a ring via X, when R 1 and R 2a form a ring via X, R 1 and R 2a are each a bond or a divalent C 1-5 acyclic hydrocarbon group optionally having substituents, and X is a bond, an oxygen atom, an optionally oxidized sulfur atom or an imino group optionally having a substituent, provided that R 1 , R 2a and X are not bonds at the same time, or a salt thereof, and an agent for inhibiting kinase (phosphorylation enzyme), which contains this compound or a prodrug thereof. The compound of the present invention has an inhibitory activity against kinase such as a vascular endothelial growth factor receptor (VEGFR) and the like, and is useful as an agent for the prophylaxis or treatment of cancer and the like.

  本发明涉及一种化合物，其表示为以下式子： 其中，A是苯环，可选地具有取代基，R1、R2a和R3分别是氢原子、可选地具有取代基的碳氢基团或可选地具有取代基的杂环基团，当R1和R2a通过X形成环时，R1和R2a可以是一个键或可选地具有取代基的双价C1-5非环烃基团，X是键、氧原子、可选地氧化的硫原子或可选地具有取代基的亚胺基团，前提是R1、R2a和X不同时为键，或其盐，以及一种抑制激酶（磷酸化酶）的药剂，其含有该化合物或其前药。 本发明的化合物具有对激酶（如血管内皮生长因子受体（VEGFR）等）的抑制活性，可用作预防或治疗癌症等疾病的药剂。
• 4-FLUORO-4-ARYLPIPERDIN-1-YL DERIVATIVES AS MU OPIOID FUNCTION MODERATORS
  申请人：Fairfax David J.

  公开号：US20130045165A1

  公开（公告）日：2013-02-21

  4-Fluoro-4-phenylpiperidin- 1 -yl μ antagonists of general structure as well as pharmaceutical compositions comprising compounds of formula I, are disclosed. These compounds and compositions are useful as treatments of conditions or diseases associated with binding opioid receptors including pain, obesity, hyperalgesia, inflammation, osteoarthritis, drug addiction, and cancer. These compounds and compositions are also useful as treatments for tardive dyskinesia.

  本发明涉及一种通用结构的4-氟-4-苯基哌啶-1-基μ拮抗剂，以及包含式I化合物的制药组合物。这些化合物和组合物可用于治疗与结合阿片受体有关的疾病或症状，包括疼痛、肥胖症、高痛敏性、炎症、骨关节炎、药物成瘾和癌症。这些化合物和组合物还可用于治疗迟发性运动障碍。
• INDOLE DERIVATIVE AND USE FOR TREATMENT OF CANCER
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1761539A1

  公开（公告）日：2007-03-14